Researchers projected CT use in 2023 would lead to more than 100,000 future cancer diagnoses, and if trends continued, may ...

Careful examination of clinical trial data and a better understanding of risk factors can help rheumatologists determine if a ...

As recently as March, the FDA approved the IL-23 inhibitor guselkumab (Tremfya, Johnson & Johnson/Janssen) for patients with Crohn’s disease, offering both IV and subcutaneous induction options.

Using an ophthalmic exoscope with an augmented reality headset instead of a standard operating microscope may yield ergonomic ...

Immunoengineering, which has been beneficial to other medical specialties, could be used in the infectious diseases field to ...

CeraVe and Neutrogena over-the-counter products topped the U.S. News & World Report third annual Best OTC Medicine & Health ...

Annual universal depression screening for adolescents during primary care visits is cost effective, especially for certain ...

Treatment with stimulants is unlikely to cause psychotic symptoms in children with ADHD, according to a new study published ...

A carotid stenting system was linked to the lowest 1-year stroke rates reported for any prospective, multicenter pivotal ...

When we are looking at the role of a mental health professional, we are bridging this gap between physical healing and ...

There are limits to cell therapy delivery in patients requiring extracorporeal membrane oxygenation due to the machine, but ...

Adults with mild autonomous cortisol secretion who undergo an adrenalectomy have a significantly reduced risk for vertebral ...